跳至主要内容
临床试验/NCT01337830
NCT01337830已完成1 期

A Randomized, Double-Blind, Crossover, Pilot Study to Evaluate the Safety and Efficacy of Ariva® Silver Wintergreen, a Smoking Aversive Lozenge, in Reducing Craving for a Cigarette in Daily Smokers

Star Scientific, Inc1 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2010年10月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
111
试验地点
1
主要终点
Effectiveness of Ariva® Silver Wintergreen lozenge on reducing craving for a cigarette in daily smokers

研究概览

简要总结

Study to determine the safety and effectiveness of Ariva® Silver Wintergreen lozenge on reducing craving for a cigarette in daily smokers.

详细描述

Each subject will be given an Ariva® Silver Wintergreen lozenge or a Silver Wintergreen lozenge, which contains only silver salt, on a random basis.

Once the lozenge has dissolved in the mouth, subjects will smoke one of their own cigarettes, and will answer questions about the experience and their craving for a cigarette.

After a washout period, each subject will repeat the steps with the second type of lozenge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
23 Years 至 72 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •healthy adult smoker
  • •smoking for at least 5 years
  • •smoking at least one (1) pack of cigarettes a day
  • •interest in quitting smoking

排除标准

  • •known allergy to silver or silver salts
  • •pregnant or breast-feeding
  • •current drug or alcohol abuse, and/or history of drug or alcohol dependence within 3 months of study

研究组 & 干预措施

Ariva® Silver Wintergreen

Experimental

Subjects allow study product lozenge to dissolve in the mouth, smoke a cigarette, then answer questionnaires about the effect of the product on both their desire to smoke and on cigarette taste.

干预措施: Ariva® Silver Wintergreen (Other)

Silver Wintergreen

Active Comparator

Subjects allow comparator product lozenge to dissolve in the mouth, smoke a cigarette, then answer questionnaires about the effect of the product on both their desire to smoke and on cigarette taste.

干预措施: Silver Wintergreen (Other)

结局指标

主要结局

Effectiveness of Ariva® Silver Wintergreen lozenge on reducing craving for a cigarette in daily smokers

时间窗: 90 minutes

Effectiveness to be measured by the change in score on a craving questionnaire, from before to after product use.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Pilot Study to Evaluate the Safety and Efficacy of... | 临床试验